CompuGroup Medical US announced the CEO transition

Michael Rauch expresses confidence in Benedikt Brueckle's leadership, anticipating continued innovation and excellence in healthcare IT under his guidance

In a demonstration of its steadfast commitment to its second-largest market worldwide in terms of revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Brueckle, a respected and seasoned leader in the healthcare IT sector, will succeed Derek Pickell, who is scheduled to retire at the end of 2024 following a distinguished tenure. The company has also experienced significant customer growth during this period. With an expanded presence in the physician office space, CGM US is well-positioned to drive the digitalization of the patient journey.

Brueckle, with over 13 years of experience at CompuGroup Medical and being instrumental in the acquisition of eMDs in 2020, is uniquely qualified to lead CompuGroup Medical US into its next phase. His track record of success in healthcare technology and expertise in innovation and strategic partnerships will be vital as the company navigates the evolving healthcare landscape. Brueckle highlights CGM US's unique proposition in the ambulatory market with its ambulatory and laboratory information systems and emphasizes the company's position as the sole vendor offering ambulatory electronic health records and practice management systems alongside its own medical clearinghouse, eMEDIX, and Laboratory Information System (LIS). Brueckle expresses confidence in CGM US's ability to sustain profitable growth moving forward.